Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism MST1 inhibitors(macrophage stimulating 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H22N6O3S |
InChIKeyFWEIAKDAIDQPRK-UHFFFAOYSA-N |
CAS Registry2414484-25-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | CN | 29 Aug 2022 |